Guggenheim Capital’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-4,038
| Closed | -$22K | – | 2542 |
|
|
2018
Q1 | $22K | Buy |
4,038
+24
| +0.6% | +$131 | ﹤0.01% | 2739 |
|
|
2017
Q4 | $27K | Sell |
4,014
-501
| -11% | -$3.37K | ﹤0.01% | 2659 |
|
|
2017
Q3 | $26K | Buy |
4,515
+451
| +11% | +$2.6K | ﹤0.01% | 2728 |
|
|
2017
Q2 | $34K | Hold |
4,064
| – | – | ﹤0.01% | 2751 |
|
|
2017
Q1 | $55K | Buy |
4,064
+24
| +0.6% | +$325 | ﹤0.01% | 2727 |
|
|
2016
Q4 | $18K | Hold |
4,040
| – | – | ﹤0.01% | 2856 |
|
|
2016
Q3 | $23K | Buy |
+4,040
| New | +$23K | ﹤0.01% | 2816 |
|